Patents by Inventor Wanxia He

Wanxia He has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050032038
    Abstract: The invention provides methods to identify specific inhibitors of HPV E7 binding to CDK2 complex and methods to identify specific inhibitors of E7-induced CDK2 kinase activity. Specific inhibitors identified by the methods, compositions comprising the specific inhibitors, and methods of treatment using the compounds are also provided.
    Type: Application
    Filed: September 8, 2003
    Publication date: February 10, 2005
    Inventors: Christopher Fisher, Wanxia He
  • Patent number: 6641994
    Abstract: The invention provides methods to identify specific inhibitors of HPV E7 binding to CDK2 complex and methods to identify specific inhibitors of E7-induced CDK2 kinase activity. Specific inhibitors identified by the methods, compositions comprising the specific inhibitors, and methods of treatment using the compounds are also provided.
    Type: Grant
    Filed: December 1, 2000
    Date of Patent: November 4, 2003
    Assignee: Pharmacia & Upjohn Company
    Inventors: Christopher Fisher, Wanxia He
  • Publication number: 20010029022
    Abstract: The invention provides methods to identify specific inhibitors of HPV E7 binding to CDK2 complex and methods to identify specific inhibitors of E7-induced CDK2 kinase activity. Specific inhibitors identified by the methods, compositions comprising the specific inhibitors, and methods of treatment using the compounds are also provided.
    Type: Application
    Filed: December 1, 2000
    Publication date: October 11, 2001
    Inventors: Christopher Fisher, Wanxia He
  • Patent number: 6200746
    Abstract: The invention provides methods to identify specific inhibitors of HPV E7 binding to CDK2 and methods to identify specific inhibitors of E7-induced CDK2 kinase activity. Specific inhibitors identified by the methods, compositions comprising the specific inhibitors, and methods of treatment using the compounds are also provided.
    Type: Grant
    Filed: August 25, 1999
    Date of Patent: March 13, 2001
    Assignee: Pharmacia & Upjohn Company
    Inventors: Christopher Fisher, Wanxia He